BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15685241)

  • 1. Expression of the proapoptotic protein Bid is an adverse prognostic factor for radiotherapy outcome in carcinoma of the cervix.
    Green MM; Hutchison GJ; Valentine HR; Fitzmaurice RJ; Davidson SE; Hunter RD; Dive C; West CM; Stratford IJ
    Br J Cancer; 2005 Feb; 92(3):449-58. PubMed ID: 15685241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of p53 and Bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIb/III patients treated by radiotherapy.
    Jain D; Srinivasan R; Patel FD; Kumari Gupta S
    Gynecol Oncol; 2003 Jan; 88(1):22-8. PubMed ID: 12504622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix.
    Loncaster JA; Cooper RA; Logue JP; Davidson SE; Hunter RD; West CM
    Br J Cancer; 2000 Sep; 83(5):620-5. PubMed ID: 10944602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of c-erbB-2 protein expression in carcinoma of the cervix treated with radiotherapy.
    Nishioka T; West CM; Gupta N; Wilks DP; Hendry JH; Davidson SE; Hunter RD
    J Cancer Res Clin Oncol; 1999; 125(2):96-100. PubMed ID: 10190316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix.
    West CM; Davidson SE; Roberts SA; Hunter RD
    Br J Cancer; 1997; 76(9):1184-90. PubMed ID: 9365167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma.
    Levine EL; Renehan A; Gossiel R; Davidson SE; Roberts SA; Chadwick C; Wilks DP; Potten CS; Hendry JH; Hunter RD
    Radiother Oncol; 1995 Oct; 37(1):1-9. PubMed ID: 8539450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
    Wootipoom V; Lekhyananda N; Phungrassami T; Boonyaphiphat P; Thongsuksai P
    Gynecol Oncol; 2004 Sep; 94(3):636-42. PubMed ID: 15350352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma.
    Coutinho-Camillo CM; Lourenço SV; Nishimoto IN; Kowalski LP; Soares FA
    Histopathology; 2010 Aug; 57(2):304-16. PubMed ID: 20716171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic factors and response to radiotherapy in carcinoma of the cervix.
    Mukherjee G; Freeman A; Moore R; Kumaraswamy ; Devi KU; Morris LS; Coleman N; Dilworth S; Prabhakaran PS; Stanley MA
    Int J Gynecol Cancer; 2001; 11(3):187-93. PubMed ID: 11437923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bax and Bcl-2 expression predict response to radiotherapy in human cervical cancer].
    Harima Y; Oka A; Nagata K; Harima K; Tanaka Y; Shikata N
    Gan To Kagaku Ryoho; 1998 Jul; 25(9):1273-7. PubMed ID: 9703806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of prognostic effect of carbonic anhydrase-9, hypoxia inducible factor-1α and bcl-2 in 286 patients with early squamous cell carcinoma of the glottic larynx treated with radiotherapy.
    Douglas CM; Bernstein JM; Ormston VE; Hall RC; Merve A; Swindell R; Valentine HR; Slevin NJ; West CM; Homer JJ
    Clin Oncol (R Coll Radiol); 2013 Jan; 25(1):59-65. PubMed ID: 22841149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of hypoxic-inducible factor 1alpha predicts metastasis-free survival after radiation therapy alone in stage IIIB cervical squamous cell carcinoma.
    Ishikawa H; Sakurai H; Hasegawa M; Mitsuhashi N; Takahashi M; Masuda N; Nakajima M; Kitamoto Y; Saitoh J; Nakano T
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):513-21. PubMed ID: 15380586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Bcl-2 family member Bid in normal and malignant tissues.
    Krajewska M; Zapata JM; Meinhold-Heerlein I; Hedayat H; Monks A; Bettendorf H; Shabaik A; Bubendorf L; Kallioniemi OP; Kim H; Reifenberger G; Reed JC; Krajewski S
    Neoplasia; 2002; 4(2):129-40. PubMed ID: 11896568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma.
    Cho NH; Kim YB; Park TK; Kim GE; Park K; Song KJ
    Gynecol Oncol; 2003 Nov; 91(2):346-53. PubMed ID: 14599865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis.
    Rofstad EK; Sundfør K; Lyng H; Tropé CG
    Br J Cancer; 2000 Aug; 83(3):354-9. PubMed ID: 10917551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit is collaboration with pro-apoptotic Bak or Bax.
    Werner AB; de Vries E; Tait SW; Bontjer I; Borst J
    J Biol Chem; 2002 Jun; 277(25):22781-8. PubMed ID: 11929871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation therapy induced changes in apoptosis and its major regulatory proteins, Bcl-2, Bcl-XL, and Bax, in locally advanced invasive squamous cell carcinoma of the cervix.
    Adhya AK; Srinivasan R; Patel FD
    Int J Gynecol Pathol; 2006 Jul; 25(3):281-7. PubMed ID: 16810067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between the tumoral expression of beta3-integrin and outcome in cervical cancer patients who had undergone radiotherapy.
    Gruber G; Hess J; Stiefel C; Aebersold DM; Zimmer Y; Greiner RH; Studer U; Altermatt HJ; Hlushchuk R; Djonov V
    Br J Cancer; 2005 Jan; 92(1):41-6. PubMed ID: 15597101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bax and Bcl-2 protein expression following radiation therapy versus radiation plus thermoradiotherapy in stage IIIB cervical carcinoma.
    Harima Y; Nagata K; Harima K; Oka A; Ostapenko VV; Shikata N; Ohnishi T; Tanaka Y
    Cancer; 2000 Jan; 88(1):132-8. PubMed ID: 10618615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proapoptotic Bad and Bid protein expression predict survival in stages II and III colon cancers.
    Sinicrope FA; Rego RL; Foster NR; Thibodeau SN; Alberts SR; Windschitl HE; Sargent DJ
    Clin Cancer Res; 2008 Jul; 14(13):4128-33. PubMed ID: 18593990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.